Spyros Papapetropoulos - 27 Aug 2025 Form 4 Insider Report for Neuphoria Therapeutics Inc. (NEUP)

Role: President and CEO, Director
Signature: /s/ Spyros Papapetropoulos
Issuer symbol: NEUP
Transactions as of: 27 Aug 2025
Net transactions value: +$285,803
Form type: 4
Filing time: 02 Sep 2025, 07:02:44 UTC
Previous filing: 05 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Papapetropoulos Spyros	President and CEO, Director	100 SUMMIT DRIVE, BURLINGTON	/s/ Spyros Papapetropoulos	01 Sep 2025	0001832694

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEUP	Employee Stock Option (Right-to- Buy)	Award	$285,803	+34,559	+87%	$8.27	74,088	27 Aug 2025	Common Stock	34,559	$8.27	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to the Reporting Person's continuing service with the Company, the options shall vest on a monthly basis over a four-year period at the rate of 2.0833% of the shares of Common Stock on the last day of each month following August 1, 2025 until the options are fully vested.